Organon Stock Jumps as Sun Pharma’s Reported $13 Billion Bid Puts OGN in Takeover Spotlight
Organon shares jumped 25% Friday after The Economic Times reported Sun Pharma made a binding $13 billion all-cash takeover offer, backed by $12 billion in bank financing. Sun Pharma shares fell over 3% in Mumbai. Neither company has confirmed a deal. Organon, based in Jersey City, posted $6.2 billion in 2025 revenue and holds $8.64 billion in debt.